Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2006
05/25/2006US20060111279 Glycopegylated erythropoietin
05/25/2006US20060111278 TFF peptides
05/25/2006US20060111275 Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols
05/25/2006US20060110803 Antigenic peptides of SARS coronavirus and uses thereof
05/25/2006US20060110802 DNA encoding novel 4-1BB ligand (4-1BB-L) polypeptides which are members of the tumor necrosis factor (TNF) receptor super-family; expression vectors and antibodies; use to stimulate proliferation of activated T-cells for immunotherapy
05/25/2006US20060110801 Receptor for b. anthracis toxin
05/25/2006US20060110800 Testis-specific receptor
05/25/2006US20060110794 Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
05/25/2006US20060110793 Methods and compositions for increasing longevity and protein yield from a cell culture
05/25/2006US20060110792 Potassium channels, nucleotide sequences encoding them, and methods of using same
05/25/2006US20060110790 Expression system for large functional proteins
05/25/2006US20060110782 cycloalkyne compounds reacting with an azide moiety on a target biomolecule, by biochemical conjugation; for its application in vivo (on the cell surface or intracellularly) or in vitro (synthesis of peptides); labeling
05/25/2006US20060110777 Structured peptide scaffold for displaying turn libraries on phage
05/25/2006US20060110776 Monoclonal antibodies for binding to native proBNP to diagnose heart failure and hybridomas to produce antibodies
05/25/2006US20060110775 Monoclonal antibodies for binding to native proBNP to diagnose heart failure and hybridomas to produce antibodies
05/25/2006US20060110773 Marker for inflammatory conditions
05/25/2006US20060110772 Human and murine cytokine polypeptides
05/25/2006US20060110771 Proteins capable of binding to female sex hormones and process for producing the same
05/25/2006US20060110761 Identification of a gene causing the most common form of Bardet-Biedl syndrome and uses thereof
05/25/2006US20060110742 Carrier tests for polycystic kidney disease in the cat
05/25/2006US20060110737 Human tumor-associated gene ct120 on chromosome 17p 13.3 region and the protein encoded by it
05/25/2006US20060110736 Hiv vaccine formulations
05/25/2006US20060110734 conducting a bioassay on a DNA sample or an RNA sample, to determine the presence or absence of gene mutations associated with a genetic disorder with clinical features including exocrine pancreatic insufficiency, haematological dysfunction and skeletal abnormalities
05/25/2006US20060110731 Cancer-linked gene as target for chemotherapy
05/25/2006US20060110730 Methods and compositions for regulation and manipulation of steroidogenesis
05/25/2006US20060110729 Method of dna testing for mycobacterium paratuberculosis strains
05/25/2006US20060110437 Synthesis and self-assembly of abc triblock bola peptide
05/25/2006US20060110425 Leech extracts for stents
05/25/2006US20060110412 Vaccine composition
05/25/2006US20060110410 Recombinant toxin fragments
05/25/2006US20060110409 Targeted agents for nerve regeneration
05/25/2006US20060110408 Immunological combination compositions and methods
05/25/2006US20060110404 Set of ubiquitous cellular proteins involved in viral life cycle
05/25/2006US20060110401 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof
05/25/2006US20060110400 Immunogenic conjugates
05/25/2006US20060110393 Novel proteins and use thereof
05/25/2006US20060110391 Compositions and methods for the treatment of body weight disorders, including obesity
05/25/2006US20060110386 Monoclonal antibody or an antigen binding fragment thereof which binds with selectivity to a human IL-B50 receptor complex comprising a human IL7R alpha subunit
05/25/2006US20060110385 Means and methods for diagnosing and treating affective disorders
05/25/2006US20060110384 Novel proteins and use thereof
05/25/2006US20060110380 Compositions for inhibiting thrombin-induced coagulation and methods of use
05/25/2006US20060110377 Immunologically privileged cells and uses thereof
05/25/2006US20060110376 MDA-7 and free radicals in the treatment of cancer
05/25/2006US20060110362 Sequences upstream of the CARP gene, vectors containing them and uses thereof
05/25/2006US20060110360 Methods of treating tumors using natural killer cell lines
05/24/2006EP1659180A2 Flowering time modification
05/24/2006EP1659179A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
05/24/2006EP1659178A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
05/24/2006EP1659177A2 Secreted and transmembrane polypeptides and nucleic acids ancoding the same
05/24/2006EP1659175A1 Alterations in seborrheic keratoses and their applications
05/24/2006EP1659133A2 Human-murine chimeric antibodies against respiratory syncytial virus
05/24/2006EP1659132A1 Biologically active bactericidal/permeability-increasing protein fragments
05/24/2006EP1659131A2 Polypeptides and nucleic acids encoding the same
05/24/2006EP1658856A1 Exendins for glucagon suppression
05/24/2006EP1658506A2 Methods for reducing complexity of a sample using small epitope antibodies
05/24/2006EP1658373A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof
05/24/2006EP1658370A1 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
05/24/2006EP1658367A2 Nucleic and protein sequences from the hxhv virus and uses thereof
05/24/2006EP1658312A1 Modulators of the potassium channels twik-1, task-1, girk1, sk2 or pcn1, used to treat arrhythmia, coronary heart disease or hypertension
05/24/2006EP1658311A2 Enhancing the circulating half-life of interleukin-2 proteins
05/24/2006EP1658310A1 Promoter of the human fatp5 gene and uses
05/24/2006EP1658309A2 Peptide protein translation inhibitor and the use thereof for protein translation control
05/24/2006EP1658308A1 Muteins of a bilin-binding protein with affinity for a given target
05/24/2006EP1658307A2 Methods for the early diagnosis of ovarian cancer
05/24/2006EP1658303A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
05/24/2006EP1658036A2 Estrogen receptor modulators and uses thereof
05/24/2006EP1608678A4 Process for isolating haemocyanin
05/24/2006EP1466614A4 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
05/24/2006EP1423418B1 Mutated env gene, mutated env glycoprotein and the use thereof
05/24/2006EP1419277B1 Isolation of membrane bound ligand-specific complexes
05/24/2006EP1416791B1 An animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
05/24/2006EP1383480A4 Lipid-comprising drug delivery complexes and methods for their production
05/24/2006EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof
05/24/2006EP1301636A4 Method for determining three-dimensional protein structure from primary protein sequence
05/24/2006EP1297015B1 Structure based drug design method to identify compounds that bind to cd81, a cell receptor for hepatitis-c
05/24/2006EP1252183B1 Method for reducing the immunogenicity of staphylokinase by elimination of t-cell epitopes
05/24/2006EP1227848B1 Method for linking molecular substances
05/24/2006EP1141305B1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum
05/24/2006EP1124967B1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS
05/24/2006EP1121382B1 Interferon-beta fusion proteins and uses
05/24/2006EP1071443B1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
05/24/2006EP1017836B1 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
05/24/2006EP1015585B1 Tie ligand homologues
05/24/2006EP1009419B1 Method for identifying modified recombinant Graminae pollen allergens
05/24/2006EP1002075B1 Adipocyte-specific protein homologs
05/24/2006EP0907733B1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/24/2006EP0892809B1 Fhit proteins and nucleic acids and methods based thereon
05/24/2006DE102005028117A1 Diagnostik und Therapie von Autophagie-assoziierten Erkrankungen Diagnosis and treatment of autophagy-associated diseases
05/24/2006CN1777807A Method of screening inhibitor by using induction of interleukin 18 production by keratinocyte, method of inducing atopic dermatitis-like symptom and utilization of the same
05/24/2006CN1777680A Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells
05/24/2006CN1777678A Method of treating ischemic disease
05/24/2006CN1777677A Enhanced amylose production in plants
05/24/2006CN1777676A Schizophrenia-related voltage-gated ion channel gene and protein
05/24/2006CN1777620A Recombinant human omega interferon and its expressing method and use
05/24/2006CN1777448A Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
05/24/2006CN1777441A Rapid serological test for paratuberculosis using fluorescence polarization technology
05/24/2006CN1777439A Somatostatin vectors
05/24/2006CN1777437A Biologically active native biomatrix composition
05/24/2006CN1775946A Enhanced virus-mediated DNA transfer
05/24/2006CN1775809A Bt CrylA antibody, and its preparing method and special antigen and use